Multiple system atrophy (MSA) is a rare disorder with limited treatment options. However, recent research has yielded promising developments into new therapeutic approaches. Current focus centers on addressing the underlying pathophysiology of MSA. One avenue under investigation involves drug-based interventions to regulate the activity of specifi